Algert Global’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-20,926
| Closed | -$90K | – | 1179 |
|
|
2023
Q3 | $90K | Sell |
20,926
-4,194
| -17% | -$18K | ﹤0.01% | 1038 |
|
|
2023
Q2 | $138K | Buy |
+25,120
| New | +$138K | 0.01% | 1015 |
|
|
2022
Q4 | – | Sell |
-14,870
| Closed | -$38K | – | 1188 |
|
|
2022
Q3 | $38K | Hold |
14,870
| – | – | ﹤0.01% | 1144 |
|
|
2022
Q2 | $54K | Buy |
14,870
+1,760
| +13% | +$6.39K | ﹤0.01% | 1149 |
|
|
2022
Q1 | $81K | Buy |
+13,110
| New | +$81K | 0.01% | 1117 |
|
|
2020
Q1 | – | Sell |
-25,964
| Closed | -$79K | – | 457 |
|
|
2019
Q4 | $79K | Sell |
25,964
-37,053
| -59% | -$113K | 0.02% | 356 |
|
|
2019
Q3 | $194K | Buy |
63,017
+11,890
| +23% | +$36.6K | 0.07% | 282 |
|
|
2019
Q2 | $102K | Sell |
51,127
-23,537
| -32% | -$47K | 0.04% | 317 |
|
|
2019
Q1 | $322K | Sell |
74,664
-298,417
| -80% | -$1.29M | 0.18% | 178 |
|
|
2018
Q4 | $1.19M | Sell |
373,081
-50,334
| -12% | -$160K | 0.33% | 102 |
|
|
2018
Q3 | $2.22M | Buy |
423,415
+130,058
| +44% | +$683K | 0.48% | 64 |
|
|
2018
Q2 | $1.57M | Buy |
293,357
+31,578
| +12% | +$169K | 0.33% | 120 |
|
|
2018
Q1 | $1.31M | Buy |
261,779
+74,357
| +40% | +$372K | 0.25% | 146 |
|
|
2017
Q4 | $618K | Buy |
187,422
+38,328
| +26% | +$126K | 0.15% | 213 |
|
|
2017
Q3 | $559K | Buy |
149,094
+35,276
| +31% | +$132K | 0.13% | 215 |
|
|
2017
Q2 | $290K | Hold |
113,818
| – | – | 0.08% | 249 |
|
|
2017
Q1 | $296K | Buy |
113,818
+17,120
| +18% | +$44.5K | 0.08% | 264 |
|
|
2016
Q4 | $295K | Buy |
96,698
+48,030
| +99% | +$147K | 0.08% | 265 |
|
|
2016
Q3 | $132K | Buy |
+48,668
| New | +$132K | 0.04% | 350 |
|